How 3D Printing Is Saving Lives

Best known for its use in prototypes, additive manufacturing — better known as 3D printing — is being used by companies big and small for developing the latest products. With additive manufacturing technology becoming more accessible and cheaper every year, one can easily envision a time when every hospital –maybe every doctor’s office--has one on-hand.

Following up on a story aired on NPR, Joel Hans of reported on yet another use of 3D printing. Garrett Peterson was born with a condition known as tracheomalacia, which meant his trachea was so weak that it was very susceptible to collapsing during the most routine of acts. The collapsed trachea would leave him unable to breathe, and his mother reports watching him turn blue many times while waiting for hospital staff to help reopen his windpipe. The condition has meant that in this first 16 months of life, Garrett had never been able to leave the hospital.

Dr. Glenn Green, who works out of the University of Michigan, teamed up with Scott Hollister, who is a biomedical engineer at the university’s 3-D Printing Lab. Together, they came up with the solution: build small splints that would help keep Garrett’s trachea open until it was strong enough to do so itself. First, they had to take a CT scan of Garrett’s windpipe in order to build a 3D replica of it. That allowed them, in turn, to design the splints — small flexible tubes designed to fit around the windpipe and prop it open permanently.

Hans reported that Garrett’s splint has “an intricate spiral design that would have been very difficult to make using other processes like injection molding. 3D printing was critical to make this design. Also, because we are making customized devices based on patient anatomy, 3D printing made it possible to modify the design and build it in a day and a half.”

Even with the splints printed, Green and Hollister almost weren’t able to see their efforts through — the FDA hadn’t approved the plan for safety or effectiveness, as it does with other medical devices or medications. Luckily, Green and Hollister were able to secure an emergency waiver because, at that point, it was a life-or-death situation — by the time he went into surgery, one of Garrett’s lungs was completely white.

Green said Garrett “would have died without intervention. Unfortunately, we have had other potential candidates that have died before we could.”

Green hopes to expand this type of design and surgery in the future, but the FDA will likely remain a major roadblock along the way. In Garrett’s case, everything worked out for the best, but it’s a signal that the agency will likely need to deal with, quite soon, the possibility of more medical devices being custom-made for a patient’s unique needs.

On the FDA issue Green and Hollister said, “3D printing will be a challenge for the FDA as you obviously can make custom implants and can readily change design. This raises issues about how to implement FDA quality systems requirements (QSR). Also, how do you verify and validate such processes? These are challenges that we face and will require new approaches in regulatory science.”

Printing some human tissue types is already a reality. Gabor Forgacs from the University of Missouri in Columbia and colleagues printed blood vessels and sheets of cardiac tissue that “beat” like a real heart. The work was published in March 2008 in the journal Tissue Engineering. Forgacs and others started a company called Organovo to bring these products to market.

A group at the German Fraunhofer Institute has also created blood vessels, by printing artificial biological molecules with a 3D inkjet printer and zapping them into shape with a laser.

Researchers are working on developing a “heart patch” made of 3D-printed cells that could repair damaged hearts. Ralf Gaebel of the University of Rostock, Germany, and colleagues made such a patch using a computerized laser-based printing technique. They implanted patches made of human cells in the hearts of rats that had suffered heart attacks; the rats’ hearts that were patched showed improvement in function, the scientists reported in December 2011 in the journal Biomaterials.

With additive manufacturing technology becoming more accessible and cheaper every year, one can easily envision a time when every hospital has one on-hand. Hollister says that the materials and machine time only cost about $100, although the R&D and regulatory expenses are in the thousands.




  • Get the CEO Briefing

    Sign up today to get weekly access to the latest issues affecting CEOs in every industry
  • upcoming events